Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Tokyo
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

ASKA Pharmaceutical Co Ltd

+ Add to Watchlist

4514:JP

1,252.0 JPY 14.0 1.11%

As of 02:00:00 ET on 05/29/2015.

Snapshot for ASKA Pharmaceutical Co Ltd (4514)

Open: 1,266.0 Day's Range: 1,248.0 - 1,275.0 Volume: 81,100
Previous Close: 1,266.0 52wk Range: 926.0 - 1,500.0 1-Yr Rtn: +32.08%

Stock Chart for 4514

No chart data available.
  • 4514:JP 1,249.0
  • 1D
  • 1M
  • 1Y
1,266.0
Interactive 4514 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 4514

Current P/E Ratio (ttm) 29.1780
Estimated P/E(03/2016) -
Relative P/E vs. TPX 1.5379
Earnings Per Share (JPY) (ttm) 42.9090
Est. EPS (JPY) (03/2016) 52.4000
Est. PEG Ratio -
Market Cap (M JPY) 38,265.13
Shares Outstanding (M) 30.56
30 Day Average Volume 87,037
Price/Book (mrq) 0.9534
Price/Sale (ttm) 0.8122
Dividend Indicated Gross Yield 1.12%
Cash Dividend (JPY) 7.0000
Dividend Ex-Date 09/28/2015
5 Year Dividend Growth 0.00%
Next Earnings Announcement 08/04/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 4514

  • Revenue
  • Net Income (M/JPY)
  • Profit Margin (%)

Company Profile & Key Executives for 4514

ASKA Pharmaceutical Co., Ltd. produces, wholesales, imports, and exports medical equipment, medical drugs, clinical reagents for human and veterinary use. The Company mainly sells its products through Takeda Chemical Industries. ASKA Pharmaceutical also manufactures raw materials for the medicine and conducts clinical tests and provides service of sterilizing medical equipment.

Takashi YamaguchiPresidentMasao YamaguchiExecutive Vice President
Atsushi MaruoExecutive DirectorKazuhiko KatoExecutive Corporate Officer
More Company Profile & Key Executives for 4514

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil